★ Sign in to follow
OP

Oasmia Pharmaceutical AB Stock: price and insider trades · Sweden

ISIN SE0000722365SE·

No insider purchase over the last 90 days. The latest, by Anders Härfstrand, was filed 19 Aug 2021.

Oasmia Pharmaceutical AB: what insiders have been doing

Oasmia Pharmaceutical AB is a listed company. Filings by its managers are published through Finansinspektionen. The past year has been quiet: not a single insider filing for Oasmia Pharmaceutical AB. The previous disclosure was published on 25 March 2022.

The full history, which starts in 2016, counts 52 purchases against 14 sales.

Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Insider Decl.
79
Thresholds
n/a
Buy Volume
€1M
52 ops. · all time
Sell Volume
€3M
14 ops. · all time
Last declaration on 25 March 2022
Declarations79 total
  • ●
    Francois-Regis Martelet
    Verkställande direktör (VD)Executives
    20,496 SEK0FI-SE
    12,200 shares@ SEK 1.688.9% of flowBTA (betald tecknad aktie)ISIN SE0017564958FI:csv-d42d20478a24d1402be8
  • ●
    Peter Zonabend
    StyrelseledamotExecutives
    201,600 SEK0FI-SE
    120,000 shares@ SEK 1.680.3% of flowBTA (betald tecknad aktie)ISIN SE0017564958FI:csv-416e0406ea0a0460f305
  • ◆
    Francois-Regis Martelet
    Verkställande direktör (VD)Executives
    0FI-SE
    2,250,000 shares0OptionFI:csv-8baa4f6b0edc2430cb49
  • ◆
    Fredrik Järrsten
    Ekonomichef/finanschef/finansdirektörExecutives
    0FI-SE
    1,350,000 shares0OptionFI:csv-73d2a439536de07c9e27
  • ▲
    Anders Härfstrand
    StyrelseordförandeExecutives
    53,133 SEK8FI-SE
    20,000 shares@ SEK 2.656611.3% of flowAktieISIN SE0000722365FI:csv-e9b7afde36635b896086
    Canonical exit: 17 Nov 2021 (T+90)
  • ▲
    Peter Zonabend
    StyrelseledamotExecutives
    302,624 SEK25FI-SE
    100,000 shares@ SEK 3.02620.4% of flowAktieISIN SE0000722365FI:csv-67f71bc251641b0f1c2b
    Canonical exit: 14 Oct 2021 (T+90)
  • ▲
    Francois-Regis Martelet
    Verkställande direktör (VD)Executives
    121,370 SEK45FI-SE
    41,000 shares@ SEK 2.960254.0% of flowAktieISIN SE0000722365FI:csv-7fe5dd015ed235aed1f8
    Canonical exit: 11 Oct 2021 (T+90)
  • ▲
    Fredrik Järrsten
    Ekonomichef/finanschef/finansdirektörExecutives
    58,200 SEK42FI-SE
    20,000 shares@ SEK 2.91100.0% of flowAktieISIN SE0000722365FI:csv-3ab6b3a73df6e6984de7
    Canonical exit: 12 Oct 2021 (T+90)
  • ▲
    Birgit Agneta Stattin Norinder
    StyrelseledamotExecutives
    104,480 SEK27FI-SE
    35,000 shares@ SEK 2.9851100.0% of flowAktieISIN SE0000722365FI:csv-a3e069a9fd757d341ce6
    Canonical exit: 6 Oct 2021 (T+90)
  • ▲
    Anders Härfstrand
    StyrelseordförandeExecutives
    285,653 SEK13FI-SE
    100,000 shares@ SEK 2.856561.3% of flowAktieISIN SE0000722365FI:csv-cd1ea5408edaa59e96a1
    Canonical exit: 4 Oct 2021 (T+90)
  • ▲
    Francois-Regis Martelet
    VDExecutives
    85,000 SEK42FI-SE
    20,000 shares@ SEK 4.25100.0% of flowAktieISIN SE0000722365FI:csv-d3327120bdc42002f77e
    Canonical exit: 11 Jan 2021 (T+90)
  • ▲
    Anders Härfstrand
    Styrelseledamot/suppleantExecutives
    130,800 SEK15FI-SE
    30,000 shares@ SEK 4.36100.0% of flowAktieISIN SE0000722365FI:csv-04398a8a5ec6bb3718a1
    Canonical exit: 10 Jan 2021 (T+90)
  • ▼
    Sven Rohmann
    Board memberExecutives
    620,638 SEK8FI-SE
    100,000 shares@ SEK 6.206410.4% of flowAktieISIN SE0000722365FI:csv-214eab4f135348da18ee
  • ▼
    Sven Rohmann
    Board memberExecutives
    499,614 SEK8FI-SE
    80,000 shares@ SEK 6.24528.4% of flowAktieISIN SE0000722365FI:csv-6f08441e5ffaad28bf31
  • ▼
    Sven Rohmann
    Board memberExecutives
    492,724 SEK8FI-SE
    77,000 shares@ SEK 6.3998.3% of flowAktieISIN SE0000722365FI:csv-8418b1bd2d9ef0d00ca2
  • ▼
    Sven Rohmann
    Board memberExecutives
    476,657 SEK8FI-SE
    77,000 shares@ SEK 6.19048.0% of flowAktieISIN SE0000722365FI:csv-782c18fd8de62994868f
  • ▼
    Sven Rohmann
    Board memberExecutives
    486,656 SEK8FI-SE
    77,000 shares@ SEK 6.32028.2% of flowAktieISIN SE0000722365FI:csv-458515ec33a171a1d239
  • ▼
    Sven Rohmann
    Board memberExecutives
    504,703 SEK8FI-SE
    78,370 shares@ SEK 6.448.5% of flowAktieISIN SE0000722365FI:csv-ad6068a4e8448840f039
  • ●
    Sven Rohmann
    Board member and acting CEOExecutives
    1M SEK0FI-SE
    720,000 shares@ SEK 2.0024.2% of flowBTA (betald tecknad aktie)ISIN SE0013460557FI:csv-5a2fa2ce2c3310df5cea
  • ●
    Jörgen Olsson
    Styrelseledamot/suppleantExecutives
    1M SEK0FI-SE
    720,000 shares@ SEK 2.0055.0% of flowBTA (betald tecknad aktie)ISIN SE0010101188FI:csv-b4bd42bd3542f3abe426
  • ●
    Anette Sjödin
    Vice VDExecutives
    60,000 SEK0FI-SE
    30,000 shares@ SEK 2.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0013460557FI:csv-75c993cb147c086257cd
  • ▲
    Nina Heldring
    LedningsgruppsmedlemExecutives
    25,679 SEK0FI-SE
    15,105 shares@ SEK 1.7051.5% of flowTeckningsrättISIN SE0013460540FI:csv-5cf069200eaf90a41def
    Canonical exit: 27 Feb 2020 (T+90)
  • ▲
    Nina Heldring
    LedningsgruppsmedlemExecutives
    24,168 SEK0FI-SE
    12,084 shares@ SEK 2.0048.5% of flowBTA (betald tecknad aktie)ISIN SE0002941799FI:csv-c245f42db245cda6bc8b
    Canonical exit: 27 Feb 2020 (T+90)
  • ●
    Michael Carl Ewert af Winklerfelt
    Ekonomi/finanschefExecutives
    75,520 SEK0FI-SE
    37,760 shares@ SEK 2.0059.1% of flowBTA (betald tecknad aktie)ISIN SE0010101188FI:csv-78b5d8434e0065d7f3f7
  • ●
    Gunilla Öhman
    Styrelseledamot/suppleantExecutives
    80,000 SEK0FI-SE
    40,000 shares@ SEK 2.0055.3% of flowBTA (betald tecknad aktie)ISIN SE0013460557FI:csv-68d589f46c7b246d80ec

25 of 79 declarations

About Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB is a Swedish pharmaceutical company focused on developing cancer treatments. It is listed on the Stockholm Stock Exchange.

Related companies and executives

No related entities found.